Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS

被引:9
作者
Graf, Jeronimo [1 ,2 ]
Perez, Rodrigo [1 ,2 ]
Lopez, Rene [1 ,2 ]
机构
[1] Clin Alemana Santiago, Dept Paciente Crit, Ave Vitacura 5951, Vitacura 7650568, Santiago, Chile
[2] Univ Desarrollo, Fac Med, Clin Alemana, Ave Plaza 680, Las Condes 7550000, Santiago, Chile
关键词
Respiratory dead space; D-dimer; Volumetric capnography; COVID-19; FRACTION; MORTALITY;
D O I
10.1016/j.jcrc.2022.154095
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Available online xxxx Purpose: To determine whether VDPhys/VT is associated with coagulation activation and outcomes. Materials and methods: We enrolled patients with COVID-19 pneumonia who were supported by invasive mechanical ventilation and were monitored using volumetric capnography. Measurements were performed during the first 24 h of mechanical ventilation. The primary endpoint was the likelihood of being discharge alive on day 28. Results: Sixty patients were enrolled, of which 25 (42%) had high VDPhys/VT (>57%). Patients with high vs. low VDPhys/VT had higher APACHE II (10[8-13] vs. 8[6-9] points, p = 0.002), lower static compliance of the respiratory system (35[24-46] mL/cmH2O vs. 42[37-45] mL/cmH2O, p = 0.005), and higher D-dimer levels (1246 [1050-1594] ng FEU/mL vs. 792[538-1159] ng FEU/mL, p = 0.001), without differences in P/F ratio (157 [112-226] vs. 168[136-226], p = 0.719). Additionally, D-dimer levels correlated with VDPhys/VT (r = 0.530, p < 0.001), but not with the P/F ratio (r = -0.103, p = 0.433). Patients with high VDPhys/VT were less likely to be discharged alive on day 28 (32% vs. 71%, aHR = 3.393[1.161-9.915], p = 0.026). Conclusions: In critically ill COVID-19 patients, increased VDPhys/VT was associated with high D-dimer levels and a lower likelihood of being discharged alive. Dichotomic VDPhys/VT could help identify a high-risk subgroup of patients neglected by the P/F ratio. (c) 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:7
相关论文
共 33 条
[1]   Clinical and immunological features of severe and moderate coronavirus disease 2019 [J].
Chen, Guang ;
Wu, Di ;
Guo, Wei ;
Cao, Yong ;
Huang, Da ;
Wang, Hongwu ;
Wang, Tao ;
Zhang, Xiaoyun ;
Chen, Huilong ;
Yu, Haijing ;
Zhang, Xiaoping ;
Zhang, Minxia ;
Wu, Shiji ;
Song, Jianxin ;
Chen, Tao ;
Han, Meifang ;
Li, Shusheng ;
Luo, Xiaoping ;
Zhao, Jianping ;
Ning, Qin .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) :2620-2629
[2]   COVID-19 and its implications for thrombosis and anticoagulation [J].
Connors, Jean M. ;
Levy, Jerrold H. .
BLOOD, 2020, 135 (23) :2033-2040
[3]   Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery [J].
Dixon, Barry ;
Campbell, Duncan J. ;
Santamaria, John D. .
INTENSIVE CARE MEDICINE, 2008, 34 (07) :1216-1223
[4]   Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 [J].
Ferrario, CM ;
Jessup, J ;
Chappell, MC ;
Averill, DB ;
Brosnihan, KB ;
Tallant, EA ;
Diz, DI ;
Gallagher, PE .
CIRCULATION, 2005, 111 (20) :2605-2610
[5]   Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response [J].
Grasselli, Giacomo ;
Pesenti, Antonio ;
Cecconi, Maurizio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1545-1546
[6]   Clinical Characteristics of Coronavirus Disease 2019 in China [J].
Guan, W. ;
Ni, Z. ;
Hu, Yu ;
Liang, W. ;
Ou, C. ;
He, J. ;
Liu, L. ;
Shan, H. ;
Lei, C. ;
Hui, D. S. C. ;
Du, B. ;
Li, L. ;
Zeng, G. ;
Yuen, K. -Y. ;
Chen, R. ;
Tang, C. ;
Wang, T. ;
Chen, P. ;
Xiang, J. ;
Li, S. ;
Wang, Jin-lin ;
Liang, Z. ;
Peng, Y. ;
Wei, L. ;
Liu, Y. ;
Hu, Ya-hua ;
Peng, P. ;
Wang, Jian-ming ;
Liu, J. ;
Chen, Z. ;
Li, G. ;
Zheng, Z. ;
Qiu, S. ;
Luo, J. ;
Ye, C. ;
Zhu, S. ;
Zhong, N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720
[7]   Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH [J].
Iba, T. ;
Levy, J. H. ;
Wada, H. ;
Thachil, J. ;
Warkentin, T. E. ;
Levi, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (02) :415-419
[8]   Derangement of the endothelial glycocalyx in sepsis [J].
Iba, T. ;
Levy, J. H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (02) :283-294
[9]   The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases [J].
Iba, Toshiaki ;
Levy, Jerrold H. ;
Thachil, Jecko ;
Wada, Hideo ;
Levi, Marcel .
THROMBOSIS RESEARCH, 2019, 179 :11-14
[10]   Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms [J].
Jackson, Shaun P. ;
Darbousset, Roxane ;
Schoenwaelder, Simone M. .
BLOOD, 2019, 133 (09) :906-918